Prescribing Information & Guidance


SGLT2 Inhibitors in Chronic Kidney Disease (CKD) in Adults


PRESCRIBING SUPPORT INFORMATION FOR PRIMARY CARE

Updated September 2025

Document history
Approved by BLMK APC Feb 2024

View Document

Guideline Categories: Endocrinology and Diabetes

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: Canagliflozin, dapagliflozin, empagliflozin, SGLT2 inhibitors

Please use the search box to search the whole site if you can't find what you're looking for:

To top